The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron-Reference-Cited by-同舟云学术

The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

Published:2021-12-21 Issue:1 Volume:11 Page:1-5
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Zhang Li¹,Li Qianqian¹²,Liang Ziteng¹³,Li Tao¹,Liu Shuo¹,Cui Qianqian¹,Nie Jianhui¹,Wu Qian⁴,Qu Xiaowang⁴,Huang Weijin¹,Wang Youchun¹^ORCID

Affiliation:

1. Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People’s Republic of China

2. Jiangsu Recbio Technology Co., Ltd., Taizhou, People’s Republic of China

3. Graduate School of Peking Union Medical College, Beijing, People’s Republic of China

4. Translational Medicine Institute, The First People’s Hospital of Chenzhou, University of South China, Chenzhou, People’s Republic of China

Funder

National Key Research and Development Program of China

General Program of the National Natural Science Foundation of China

Beijing Municipal Science and Technology Project

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2021.2017757

Reference12 articles.

1. Heavily mutated Omicron variant puts scientists on alert

2. WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern. 2021. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern.

3. GISAID. 2021. https://www.gisaid.org/hcov19-variants/.

4. SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

5. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity

Cited by 349 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness;Frontiers in Immunology;2024-09-09

2. Evaluating the risk of SARS-CoV-2 reinfection with the Omicron or Delta variant in Wales, UK;PLOS ONE;2024-09-06

3. Signatures of top versus bottom illuminations and their predicted implications for infrared transmission microspectroscopy;Journal of Biophotonics;2024-08-11

4. Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS‐CoV‐2 neutralization;Immunity, Inflammation and Disease;2024-07

5. Virological and Mitochondriopathogical Characteristics of the SARS-CoV-2 Omicron XBB.1.16 Spike;ACS Applied Materials & Interfaces;2024-05-30